Recent News for HSDT - Helius Medical Technologies, Inc.

Date Title
Apr 7 Helius Medical Technologies, Inc. to Release First Quarter of Fiscal Year 2021 Financial Results on May 17, 2021
Mar 29 Helius Medical, Inc Receives U.S. Marketing Authorization for the PoNS™ Device
Mar 29 63 Biggest Movers From Friday
Mar 26 Helius Medical surges on FDA authorization for neuromodulation stimulator (updated)
Mar 17 Helius Medical Technologies, Inc. to Present at the Investor Summit Group’s Q1 Virtual Summit on March 23rd
Mar 17 Helius Medical Technologies, Inc. Appoints Sherrie Perkins to its Board of Directors
Mar 11 Helius Medical Technologies, Inc. (HSDT) CEO Dane Andreeff on Q4 2020 Results - Earnings Call Transcript
Mar 10 Helius Medical Technologies EPS misses by $1.69, beats on revenue
Mar 10 Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results
Mar 10 Earnings Scheduled For March 10, 2021
Feb 2 Helius Medical Technologies to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 10, 2021
Feb 1 Helius Medical Technologies, Inc. Announces Closing of $11.0 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
Jan 28 Helius Medical drops 16% after $9.6M capital raise
Jan 28 IIROC Trade Resumption - HSM
Jan 28 Helius Medical Technologies, Inc. Announces Pricing of $9.6 Million Underwritten Public Offering Priced At Market
Jan 28 IIROC Trading Halt - HSM
Jan 20 Helius Medical Technologies, Inc. Comments on the Centers for Medicare & Medicaid Services’ Announcement Regarding New Medicare Coverage Pathway for Breakthrough Medical Devices
Jan 19 Helius Medical regains Nasdaq listing compliance
Jan 19 Helius Medical Technologies, Inc. Regains Compliance with Nasdaq Listing Standards
Jan 15 Helius Medical Technologies, Inc. to Present at the Noble Capital Markets 17th Annual Small & Microcap Investor Conference
Jan 13 Sidoti Virtual Investor Conference
Jan 11 Helius Medical Technologies, Inc. Submits Response to U.S. FDA in Pursuit of De Novo Classification and Clearance of the PoNS™ Device for the Treatment of Gait Deficit Due to Symptoms of Multiple Sclerosis
Jan 5 Helius Medical Technologies, Inc. Comments on Unusual Market Activity
Jan 4 11 Health Care Stocks Moving In Monday's Intraday Session
Jan 4 Helius Medical Technologies, Inc. to Present at Four Upcoming Investor Conferences in January
Back to the Main HSDT Page...